13279-89-5Relevant articles and documents
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1 S,2 S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma
Munck Af Rosensch?ld, Magnus,Johannesson, Petra,Nikitidis, Antonios,Tyrchan, Christian,Chang, Hui-Fang,R?nn, Robert,Chapman, Dave,Ullah, Victoria,Nikitidis, Grigorios,Glader, Pernilla,K?ck, Helena,Bonn, Britta,W?gberg, Fredrik,Bj?rkstrand, Eva,Andersson, Ulf,Swedin, Linda,Rohman, Mattias,Andreasson, Theresa,Bergstr?m, Eva Lamm,Jiang, Fanyi,Zhou, Xiao-Hong,Lundqvist, Anders J.,Malmberg, Anna,Ek, Margareta,Gordon, Euan,Pettersen, Anna,Ripa, Lena,Davis, Andrew M.
, p. 7769 - 7787 (2019)
While bronchodilators and inhaled corticosteroids are the mainstay of asthma treatment, up to 50% of asthmatics remain uncontrolled. Many studies show that the cysteinyl leukotriene cascade remains highly activated in some asthmatics, even those on high-dose inhaled or oral corticosteroids. Hence, inhibition of the leukotriene C4 synthase (LTC4S) enzyme could provide a new and differentiated core treatment for patients with a highly activated cysteinyl leukotriene cascade. Starting from a screening hit (3), a program to discover oral inhibitors of LTC4S led to (1S,2S)-2-({5-[(5-chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid (AZD9898) (36), a picomolar LTC4S inhibitor (IC50 = 0.28 nM) with high lipophilic ligand efficiency (LLE = 8.5), which displays nanomolar potency in cells (peripheral blood mononuclear cell, IC50,free = 6.2 nM) and good in vivo pharmacodynamics in a calcium ionophore-stimulated rat model after oral dosing (in vivo, IC50,free = 34 nM). Compound 36 mitigates the GABA binding, hepatic toxicity signal, and in vivo toxicology findings of an early lead compound 7 with a human dose predicted to be 30 mg once daily.
Synthesis and radical polymerization of various 2-cyclopropylacrylates
De Meijere, Armin,Bagutski, Viktor,Zeuner, Frank,Fischer, Urs Karl,Rheinberger, Volker,Moszner, Norbert
, p. 3669 - 3678 (2007/10/03)
Fourteen new alkyl 2-cyclopropylacrylates 1a-n with various substituents R1-R5 were synthesized from readily available precursors by applying standard transformations such as cyanohydrin formation from an aldehyde, alcoholysis to an α-hydroxycarboxylic ester, oxidation and Wittig methylenation of an α-oxocarboxylic ester. Overall yields ranged from 33 to 54%. A new method for the hydrolysis of dimethyl cyclopropanedicarboxylates to the corresponding half-esters was developed. The α-oxocarboxylates 7g-n were prepared by dirhodium tetraacetate catalyzed cyclopropanation of alkenes 8g-n with methyl or ethyl diazopyruvate in 32-58% yield. The monomers 1a-n were characterized by 1H, 13C NMR spectroscopy, mass spectrometry and elemental analysis. The radical homopolymerizations of 1a-n were carried out with 2,2′- azabisisobutyronitrile (AIBN) as initiator in chlorobenzene at 65 °C. The highest polymer yields were obtained in the polymerizations of If and 1h or 1k and 11, i.e. from monomers with an annelated five- or six-membered ring. In the case of 1h and 1k, both the polymer yields (99 and 98%, respectively) and the glass transition temperatures (Tg) of 57 and 93 °C were significantly higher than those observed for the polymer from 1,1-bis(ethoxycarbonyl)-2-vinylcyclopropane (DECVCP), which was used as a benchmark for the monomer reactivities in the radical polymerizations of all the vinylcyclopropane derivatives 1a-n. The bicyclic monomers 1h and 1k also demonstrated drastically improved reactivities in the radical copolymerization with methyl methacrylate when compared to DECVCP. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004.
